Hepatic fibrosis grading with extracellular volume fraction from iodine mapping in spectral liver CT

•ECV can be calculated using iodine density from spectral CT (ECV-iodine).•ECV-iodine increased as hepatic fibrosis progressed.•ECV-iodine showed better diagnostic performance for detecting hepatic fibrosis than ECV calculated using HU without image registration. To determine whether hepatic extrace...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of radiology 2021-04, Vol.137, p.109604-109604, Article 109604
Hauptverfasser: Yoon, Jeong Hee, Lee, Jeong Min, Kim, Jae Hyun, Lee, Kyoung-Bun, Kim, Haeryoung, Hong, Suk Kyun, Yi, Nam-Joon, Lee, Kwang-Woong, Suh, Kyung-Suk
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•ECV can be calculated using iodine density from spectral CT (ECV-iodine).•ECV-iodine increased as hepatic fibrosis progressed.•ECV-iodine showed better diagnostic performance for detecting hepatic fibrosis than ECV calculated using HU without image registration. To determine whether hepatic extracellular volume fraction (ECV) obtained from iodine density map (ECV-iodine) can be used to estimate hepatic fibrosis grade and to compare performance with ECV measured using Hounsfield units (ECV-HU). From December 2016 to March 2019, patients who underwent liver resection or biopsy within four weeks after spectral liver CT were included. ECV-iodine and ECV-HU were calculated using the equilibrium phase. Within each of these, comparison of ECVs was made for different fibrosis grades (F0 – 1 vs. F2 – 3 vs. F4) and also for patients with compensated and decompensated cirrhosis. The diagnostic performance of ECVs in detecting clinically significant fibrosis (≥ F2) and cirrhosis (F4) was assessed using ROC analysis. A total of 144 patients (men = 98, mean age 58.1 ± 11.5 years) were included. The ECV-iodine value was significantly higher in cirrhosis (33.6 ± 6.8 %) than those with F0 – 1 (25.0 ± 3.7 %) or F2 – 3 (28.3 ± 3.4 %, P < 0.001 for all). It was significantly higher in decompensated cirrhosis than those with compensated cirrhosis (36.5 ± 7.2 % vs. 30.7 ± 5.0 %, respectively; P < 0.001). The AUC of ECV-iodine was 0.82 for detecting F2 or above (cut-off value, > 26.9 %) and 0.81 for detecting cirrhosis (cut-off value, > 29 %). ECV-iodine had a significantly higher AUC than ECV-HU for detecting F2 or above (AUC: 0.69, P 
ISSN:0720-048X
1872-7727
DOI:10.1016/j.ejrad.2021.109604